Divestiture

A key partnership is funding hundreds of activities for military children, providing stability and stress relief during deployment and injury recovery.

The opioid treatment specialist projects over $1.1B in revenue, driven by its flagship drug SUBLOCADE and a major strategic overhaul in the U.S.

A major customer delay impacts Ceragon's Q4 revenue, but the company projects significant growth in 2026, banking on a strong backlog and new markets.

A unique Boulder project tackles the housing crisis with modular homes, student builders, and a vision for a sustainable, replicable community model.

Atmus Filtration Technologies acquires Koch Filter for $450M in a major market expansion, while ADTi names a new CEO to lead a sharpened strategic focus.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

The renewable firm secures vital grid access for 2.9 GW in the UK and key approvals in Germany, setting the stage for major project divestments.

A strategic bet on ethnic grocery-anchored retail pays off as Arc Capital Partners exits a revitalized Torrance center in a $108.5 million blockbuster deal.

Facing declining revenue but armed with a strong AI vision, Unisys CEO Mike Thomson prepares to address investors at the critical Needham Growth Conference.

Amid rising geopolitical risks, Taiwan's J-Star is exiting China to build an automated factory in the US, a bold move for the micro-cap company.

While US sales numbers declined in 2025, Mazda posted record CPO figures, earned top safety honors, and saw major growth in Canada and Mexico.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

With Talya Nevo-Hacohen retiring, veteran Darrin Smith takes the helm as CIO. How will his vision shape Sabra's portfolio in a dynamic healthcare REIT market?

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

A tiny implant stimulating the vagus nerve offers new hope for severe RA. A landmark study now validates this bioelectric therapy for patients out of options.

The renewable energy giant is buying back preferred units, a move showcasing its strong liquidity and sharpening its focus on funding future growth.

Investors eye Aptiv's upcoming Q4 report for clues on its strategy for EV challenges, software delays, and a looming chip shortage in 2026.

A new study finds traditional banks reject 93% of emergency loan seekers, pushing millions toward predatory lenders with 400%+ APR. Is fintech the answer?

A landmark lawsuit claims the city’s failure to regulate vendors has decimated a community market, threatening student scholarships and small businesses.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.